1. Home
  2. PBYI vs PHD Comparison

PBYI vs PHD Comparison

Compare PBYI & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • PHD
  • Stock Information
  • Founded
  • PBYI 2010
  • PHD 2004
  • Country
  • PBYI United States
  • PHD United States
  • Employees
  • PBYI N/A
  • PHD N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • PHD Investment Managers
  • Sector
  • PBYI Health Care
  • PHD Finance
  • Exchange
  • PBYI Nasdaq
  • PHD Nasdaq
  • Market Cap
  • PBYI 171.7M
  • PHD 122.6M
  • IPO Year
  • PBYI N/A
  • PHD N/A
  • Fundamental
  • Price
  • PBYI $4.53
  • PHD $9.94
  • Analyst Decision
  • PBYI Strong Buy
  • PHD
  • Analyst Count
  • PBYI 1
  • PHD 0
  • Target Price
  • PBYI $7.00
  • PHD N/A
  • AVG Volume (30 Days)
  • PBYI 592.1K
  • PHD 67.7K
  • Earning Date
  • PBYI 11-06-2025
  • PHD 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • PHD 11.43%
  • EPS Growth
  • PBYI 434.29
  • PHD N/A
  • EPS
  • PBYI 0.97
  • PHD 1.27
  • Revenue
  • PBYI $238,062,000.00
  • PHD N/A
  • Revenue This Year
  • PBYI N/A
  • PHD N/A
  • Revenue Next Year
  • PBYI N/A
  • PHD N/A
  • P/E Ratio
  • PBYI $4.65
  • PHD $7.60
  • Revenue Growth
  • PBYI 8.63
  • PHD N/A
  • 52 Week Low
  • PBYI $2.32
  • PHD $8.30
  • 52 Week High
  • PBYI $6.07
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 52.63
  • PHD 54.40
  • Support Level
  • PBYI $4.49
  • PHD $9.87
  • Resistance Level
  • PBYI $5.22
  • PHD $9.97
  • Average True Range (ATR)
  • PBYI 0.22
  • PHD 0.04
  • MACD
  • PBYI -0.35
  • PHD -0.00
  • Stochastic Oscillator
  • PBYI 83.18
  • PHD 80.30

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.

Share on Social Networks: